The effect of preoperative liver dysfunction on cardiac surgery outcomes

被引:33
作者
Araujo, Luiz [1 ]
Dombrovskiy, Viktor [1 ]
Kamran, Wali [1 ]
Lemaire, Ashleigh [1 ]
Chiricolo, Antonio [1 ]
Lee, Leonard Y. [1 ]
Lemaire, Anthony [1 ]
机构
[1] RUTGERS, Robert Wood Johnson Med Sch, Div Cardiothorac Surg, Dept Surg, 125 Paterson St, New Brunswick, NJ 08903 USA
关键词
Coronary artery disease; Cirrhosis; Heart failure; Bleeding; HEART-SURGERY; RISK-FACTORS; CHILD-PUGH; CIRRHOSIS; OPERATIONS; DISEASE; SCORES;
D O I
10.1186/s13019-017-0636-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To determine the impact of preoperative Liver Dysfunction (LD) on outcomes after elective Coronary Artery Bypass Grafting (CABG) and Valvular surgery (VS). Methods: The Nationwide Inpatient Sample (2002-2010) was queried to identify patients with LD who had elective CABG or VS utilizing ICD-9-CM diagnosis and procedure codes. These patients were matched with the similar patients without LD (controls) by propensity score matching. Chi-square and Wilcoxon rank sum tests were used for analysis. Results: We identified 1197 patients with LD (CABG = 755; VS = 442) who were matched to 2394 controls. LD significantly increased hospital mortality after both CABG (OR = 5.19; 95% CI = 2.93-9.20) and VS (OR = 7.49; 95% CI = 3. 12-17.96). Overall rates of complications after CABG with LD were greater than in non-complicated cases (OR = 1.73; 95% CI = 1.46-2.05). Among them, there was an increase in bleeding (OR = 1.81; 95% CI = 1.44-2.28), respiratory (OR = 2. 33; 95% CI = 1.86-2.93), renal (OR = 2.79; 95% CI = 2.04-3.81), and infectious (OR = 2.93; 95% CI = 2.14-4.01) complications. In general, the rates of complications after VS with LD were also greater than in non-complicated cases (OR = 2.77; 95% CI = 2.13-3.60), specifically for bleeding (OR = 3.07; 95% CI = 2.17-4.34), respiratory (OR = 3.57; 95% CI = 2.51-5.07), renal (OR = 4.40; 95% CI = 2.80-6.92), and infectious (OR = 4.63; 95% CI = 2.85-7.51) complications. The development of LD significantly increased mean hospital length of stay (LOS) and total hospital charges after both CABG (from7.0 +/- 4.0 to 9.2 +/- 9.1 days and from $ 100,265 +/- 87,107 to $ 117,756 +/- 99,320, respectively; P < 0.0001 for both) and VS (from 7. 9 +/- 5.0 to 11.4 +/- 9.9 days and from $ 134,306 +/- 114,216 to $ 176,620 +/- 147,049, respectively; P < 0.0001 for both). Conclusions: LD worsened the outcomes after cardiac surgery. It increased rates of complications, hospital mortality, length of stay and total hospital charges after both procedures.
引用
收藏
页数:7
相关论文
共 17 条
[1]   Model for End-Stage Liver Disease Predicts Mortality for Tricuspid Valve Surgery [J].
Ailawadi, Gorav ;
LaPar, Damien J. ;
Swenson, Brian R. ;
Siefert, Suzanne A. ;
Lau, Christine ;
Kern, John A. ;
Peeler, Benjamin B. ;
Littlewood, Keith E. ;
Kron, Irving L. .
ANNALS OF THORACIC SURGERY, 2009, 87 (05) :1460-1468
[2]   Early and late outcome after elective cardiac surgery in patients with cirrhosis [J].
Bizouarn, P ;
Ausseur, A ;
Desseigne, P ;
Le Teurnier, Y ;
Nougarede, B ;
Train, M ;
Michaud, JL .
ANNALS OF THORACIC SURGERY, 1999, 67 (05) :1334-1338
[3]   The Impact of Moderate to End-Stage Renal Failure on Outcomes After Coronary Artery Bypass Graft Surgery [J].
Chikwe, Joanna ;
Castillo, Javier G. ;
Rahmanian, Parwis B. ;
Akujuo, Adanna ;
Adams, David H. ;
Filsoufi, Farzan .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2010, 24 (04) :574-579
[4]  
Deschênes M, 1999, AM J GASTROENTEROL, V94, P2193, DOI 10.1016/S0002-9270(99)00349-4
[5]   Early and late outcome of cardiac surgery in patients with liver cirrhosis [J].
Filsoufi, Farzan ;
Salzberg, Socha P. ;
Rahmanian, Parwis B. ;
Schiano, Thomas D. ;
Elsiesy, Hussien ;
Squire, Anthony ;
Adams, David H. .
LIVER TRANSPLANTATION, 2007, 13 (07) :990-995
[6]   Risk stratification in heart surgery:: comparison of six score systems [J].
Geissler, HJ ;
Hölzl, P ;
Marohl, S ;
Kuhn-Régnier, F ;
Mehlhorn, U ;
Südkamp, M ;
de Vivie, ER .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2000, 17 (04) :400-405
[7]  
Hayashida Nobuhiko, 2004, Ann Thorac Cardiovasc Surg, V10, P140
[8]  
Hsieh WC, 2015, EUR REV MED PHARMACO, V19, P2575
[9]  
Kaplan M, 2002, HEART SURG FORUM, V5, P60
[10]  
LaPar D. J., 2015, ANN THORAC SURG